IRIS - Res&Arch Institutional Research Information System - Research & Archive

FALINI, Brunangelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.989
EU - Europa 7.441
AS - Asia 5.698
SA - Sud America 979
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
Totale 23.215
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.794
SG - Singapore 2.591
IT - Italia 1.511
IE - Irlanda 1.338
UA - Ucraina 1.157
SE - Svezia 1.010
BR - Brasile 836
CN - Cina 829
HK - Hong Kong 820
RU - Federazione Russa 756
VN - Vietnam 669
DE - Germania 487
FI - Finlandia 450
KR - Corea 360
GB - Regno Unito 233
CA - Canada 112
FR - Francia 105
TR - Turchia 85
NL - Olanda 65
AR - Argentina 63
IN - India 62
PL - Polonia 62
MX - Messico 61
AT - Austria 52
CH - Svizzera 49
BD - Bangladesh 46
JP - Giappone 45
BE - Belgio 42
UZ - Uzbekistan 40
CZ - Repubblica Ceca 32
ZA - Sudafrica 29
ES - Italia 27
EC - Ecuador 21
IQ - Iraq 21
CO - Colombia 17
LB - Libano 17
ID - Indonesia 15
GR - Grecia 14
LT - Lituania 13
MA - Marocco 13
PK - Pakistan 13
PE - Perù 11
KE - Kenya 10
OM - Oman 9
VE - Venezuela 9
AZ - Azerbaigian 8
EU - Europa 8
IL - Israele 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
EG - Egitto 7
RO - Romania 7
BO - Bolivia 6
SA - Arabia Saudita 6
BG - Bulgaria 5
GE - Georgia 5
KZ - Kazakistan 5
PT - Portogallo 5
PY - Paraguay 5
CI - Costa d'Avorio 4
CR - Costa Rica 4
JM - Giamaica 4
JO - Giordania 4
NP - Nepal 4
PA - Panama 4
TN - Tunisia 4
UY - Uruguay 4
AU - Australia 3
IR - Iran 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
SN - Senegal 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
DM - Dominica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HU - Ungheria 2
LV - Lettonia 2
MY - Malesia 2
NE - Niger 2
PH - Filippine 2
PS - Palestinian Territory 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BW - Botswana 1
CM - Camerun 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
Totale 23.187
Salva come PNG Salva come JPEG
Città #
Singapore 1.643
Chandler 1.507
Dublin 1.338
Hong Kong 816
San Mateo 715
Perugia 629
Jacksonville 611
Boardman 507
Dong Ket 465
Ashburn 453
Santa Clara 379
Seoul 358
Altamura 333
Medford 302
Princeton 297
Wilmington 248
Moscow 237
Lawrence 232
Beijing 203
Ann Arbor 201
Andover 197
Munich 169
Los Angeles 129
Piscataway 119
New York 117
Helsinki 116
Des Moines 96
Saint Petersburg 85
Turku 81
Ho Chi Minh City 79
Norwalk 67
São Paulo 67
Shanghai 65
Dallas 64
Izmir 59
The Dalles 58
Woodbridge 49
Falls Church 47
Hanoi 43
Rome 43
Brussels 41
San Paolo di Civitate 41
Tokyo 41
Houston 40
Brooklyn 37
London 35
Redmond 35
Nuremberg 34
Amsterdam 33
Belo Horizonte 33
Frankfurt am Main 31
Montreal 30
Ottawa 30
Chicago 28
Warsaw 28
Council Bluffs 27
Redwood City 27
Rio de Janeiro 27
San Francisco 26
Johannesburg 25
Mexico City 22
Stockholm 22
Chennai 21
Denver 21
Foligno 21
Orem 20
Boston 19
Dearborn 19
Atlanta 18
Phoenix 18
Guangzhou 17
Auburn Hills 16
Falkenstein 16
Manchester 16
Poplar 15
Toronto 15
Haiphong 14
Milan 14
Bologna 13
Charlotte 13
Ficarazzi 13
Tashkent 13
Brasília 12
Columbus 12
Curitiba 12
Florence 12
Vienna 12
Ankara 11
Den Haag 11
Hefei 11
Philadelphia 11
Terni 11
Campinas 10
Dhaka 10
Olomouc 10
Secaucus 10
Tianjin 10
Guayaquil 9
Lappeenranta 9
Nairobi 9
Totale 14.441
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 154
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 152
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 143
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 141
Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. 135
Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction. 133
Acute leukaemia immunophenotyping in bone-marrow routine sections. 127
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biological and clinical features 126
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 122
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 119
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 116
BCOR gene alterations in hematological diseases 116
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 115
Germline NPM1 mutations lead to altered rRNA 2′-O-methylation and cause dyskeratosis congenita 114
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. 112
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features 112
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 112
ARPIR: automatic RNA-Seq pipelines with interactive report 112
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 111
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 111
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics] 109
Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives. 109
NPM1 deletion is associated with gross chromosomal rearrangements in leukemia 109
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 109
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 108
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 107
Anaplastic large cell lymphoma: pathological, molecular and clinical features. 106
Aggressive lymphomas: a convenient concept or an anatomo-pathological reality? 106
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells 106
The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues. 105
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance 105
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 104
Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification 103
Genomics of Hairy cell leukemia 101
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 100
"Designed" grafts for HLA-haploidentical stem cell transplantation. 99
Minimal residual disease levels assessed by NPM1 mutation specific RQ-PCR provide important prognostic information in AML. 97
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 97
Primay large B-cell lymphoma (PLBCL) of the retroperitoneum: a heterogeneous group of neoplasms, some of which mimic PLBCL of the mediastinum. 96
Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease 96
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. 96
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 96
Nucleophosmin regulates the stability and transcriptional activity of p53. 95
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice. 95
THE BRAF-MEK-ERK PATHWAY IN HAIRY CELL LEUKEMIA: A COMPREHENSIVE DISSECTION IN PRIMARY LEUKEMIC CELLS OF ITS BIOLOGICAL AND THERAPEUTIC RELEVANCE 94
T regulatory cell separation for clinical application. 94
Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma. 93
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 93
IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. 93
Antigen retrieval techniques in immunohistochemistry: comparison of different methods 93
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity 93
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients 93
Choroidal vasculature analysis in MEK inhibitor-associated retinopathy 93
MONOCLONAL ANTIBODIES PG-B6a AND PG-B6p RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION. 92
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 92
Acute Myeloid Leukemia with mutated nucleophosmin (NPM1). Any hope for a targeted therapy? 92
BRAF mutations in hairy-cell leukemia. 92
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 92
Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia 92
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy 92
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 92
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease 91
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 91
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. 91
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 91
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial 91
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT) 90
Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas 90
L’esclusione degli anziani dai trial clinici in corso sul trattamento delle neoplasie ematologiche 90
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 90
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 90
Richter's transformation in the heart 90
Mutant NPM1 Maintains the Leukemic State through HOX Expression 89
CHARACTERIZATION OF A NEW MONOCLONAL ANTIBODY (PG-M3) DIRECTED AGAINST THE AMINOTERMINAL PORTION OF THE PML GENE PRODUCT: IMMUNOCYTOCHEMICAL EVIDENCE FOR HIGH EXPRESSION OF PML PROTEINS ON ACTIVATED MACROPHAGES, ENDOTHELIAL CELLS, AND EPITHELIA 88
EML4-ALK rearrangement in non-small-cell lung cancer and non-tumor lung tissues. 88
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 88
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 88
Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity 87
Cellular localization and tissue distribution of PML proteins as defined by a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product. Preferential expression in postmitotic cells. 87
Nucleophosmin is required for DNA integrity and p19Arf protein stability. 87
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. 87
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 87
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 86
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 86
Any role for the nucleophosmin (NPM1) gene in myelodysplastic syndromes and acute myeloid leukemia with chromosome 5 abnormalities? 85
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 85
Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23). 85
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 85
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 85
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor 84
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 84
Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. 84
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases 83
Simultaneous occurrence of acute myeloid leukaemia with mutated nucleophosmin (NPM1) in the same family. 83
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 83
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 83
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 83
TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. 82
Evolving concepts in the pathogenesis of hairy-cell leukaemia. 82
Detection of normal and chimeric nucleophosmin in human cells. 82
Totale 9.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.618 0 0 0 0 0 202 180 56 324 102 229 525
2021/20222.962 70 550 79 184 109 41 30 785 71 161 452 430
2022/20234.805 333 868 48 405 388 537 6 220 1.716 62 165 57
2023/20241.763 128 194 102 48 18 20 406 30 151 53 303 310
2024/20254.561 132 477 182 148 610 184 239 398 931 249 626 385
2025/20264.554 814 600 418 1.119 1.350 253 0 0 0 0 0 0
Totale 24.109